FAPI PET/CT在腹膜转移癌中的应用  

Application of FAPI PET/CT in peritoneal carcinomatosis

作　　者：陈巧 李光明[1] Chen Qiao;Li Guangming(Imaging Center,the Affiliated Qingyuan Hospital(Qingyuan People′s Hospital),Guangzhou Medical University,Qingyuan 511518,China)

机构地区：[1]广州医科大学附属清远医院(清远市人民医院)影像中心,清远511518

出　　处：《中华核医学与分子影像杂志》2024年第8期509-512,共4页Chinese Journal of Nuclear Medicine and Molecular Imaging

摘　　要：腹膜转移癌患者的生存率可通过积极治疗得到明显提高。影像学评估对于临床诊断与治疗至关重要。成纤维细胞激活蛋白抑制剂(FAPI)PET/CT显像作为目前核医学研究热点,为腹膜转移癌的准确诊断提供了新途径。该文就FAPI PET/CT在腹膜转移癌的应用进行综述,包括其在腹膜转移癌诊断中的价值及其诊断局限性等。The patient survival rate of peritoneal carcinomatosis can be significantly improved by aggressive treatment.Imaging examination is crucial for clinical diagnosis and treatment of this disease.Fibroblast activation protein inhibitor(FAPI)PET/CT,as a hotspot of nuclear medicine research,provides a new way for the diagnosis of peritoneal carcinomatosis.This review summarizes the application of FAPI PET/CT in the diagnosis of peritoneal carcinomatosis,including the diagnostic value and limitations.

关 键 词：肿瘤转移 腹膜 拮抗剂和抑制剂 膜蛋白质类 成纤维细胞 正电子发射断层显像术 体层摄影术 X线计算机 

分 类 号：R735.5[医药卫生—肿瘤] R730.44[医药卫生—临床医学]